CVS Forecasts 2026 Profit Above Wall Street Estimates

CVS Health has forecast 2026 profit above Wall Street expectations and higher than its projected earnings for this year, signaling steady progress in the healthcare conglomerate’s turnaround plan.

CVS forecasts 2026 adjusted earnings of $7.00 to $7.20 per share. (Photo: PR Newswire) 

CVS shares rose more than 3% in premarket trading, Reuters reported.

The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.

“We are closing out 2025 with meaningful momentum across our businesses, and we expect another year of strong earnings growth in 2026,” Chief Financial Officer Brian Newman said.

CVS forecast 2026 adjusted earnings of $7.00 to $7.20 per share, compared with analysts’ average estimate of $7.16, according to LSEG data. The company expects total revenue of at least $400 billion next year, below analysts’ average estimate of $419.26 billion.

CVS also raised its 2025 adjusted earnings forecast to $6.60 to $6.70 per share, up from its previous range of $6.55 to $6.65.